Periodontitis Clinical Trial
Official title:
Essential Oils With and Without Alcohol: in Vivo Antibacterial Effect
The Essential oils (EO) are composed by a wide diversity of products. Therefore, their
antimicrobial activity will be related to their composition, configuration, amount and their
possible interaction. The traditional formulation containing EO (T-EO) is a complex mixture
of phenolic compounds combined with determinate EO: 0.092% of eucalyptol, 0.064% of thymol,
0.06% of methyl-salicylate and y 0.042% of menthol. All of this solved in a hydroalcoholic
vehicle containing from a 21.6% to a 26.9% of alcohol. Thus, T-EO contain ethanol, which is
a chemical compound used in order to dissolve and stabilize the numerous substances present
in the rinse. The concentration of ethanol present in the T-EO rinses, as previously said,
is more than 20%. This concentration of ethanol, higher than 20%, is been found sufficient
to dissolve the EO but insufficient to have a direct antibacterial effect. In fact, the
manufacturer presents the alcohol contain (21.6%), among others, as an inactive ingredient
in its formula. Over the years, the adequacy of the use of ethanol in mouthwashes, as well
as their effects on the surfaces of composite restorations and their possible role in
development of oropharyngeal cancer have been discussed. Although a direct cause-and-effect
correlation between the development of oropharyngeal carcinoma and the use of alcohol-based
rinses has not been demonstrated and probably it will never be (at least by epidemiological
studies), it is considered desirable to eliminate ethanol from daily mouthwashes, especially
for those patients at higher risk. Furthermore, the fact that the alcohol is present in its
formula, have produced that some clinical practitioners do not prescribe the traditional
formula due to the controversy of the issue. All this have lead to the development of new,
alcohol free formulations of EO (Af-EO).
The composition of the Af-EO is exactly the same in their active ingredients (Eucalyptol,
Thymol, Methyl-salycilate and Menthol), but sodium fluoride has been added. Some differences
are found in their inactive ingredients. These are based on the alcohol containing of the
T-EO, without presence in the Af-EO and the presence of Propylene Glycol, sodium lauryl
sulfate and sucralose in the Af-EO, without presence in the T-EO.
In order to measure the efficacy of a mouthwash against the dental plaque two different
concepts should be defined: the substantivity and antiplaque effect. The substantivity of an
oral antiseptic is defined as the prolonged adherence to the oral surfaces and its slow
release at effective doses which guarantee the persistence of the antimicrobial activity.
The more substantivity an oral antiseptic has the better. For its study in vivo, the most
popular models are those which analyze the effect that a single mouthwash has in a mature
biofilm.
The second aspect that should be studied from an oral antiseptic, the antiplaque effect, is
defined as the capacity that an agent has to avoid the formation of bacterial aggregates
(plaque) on the oral surfaces. For its study in vivo, models start from a baseline sample
with levels of plaque near to 0 in order to assess the power of the antiseptic to reduce the
formation of bacterial plaque (normally dental plaque) against the control. A clinical study
of 6 months using a determinate antiplaque agent is necessary in order to tag an antiseptic
as effective. However, in the literature, there is an established model of 4 days of plaque
regrowing which can assess the inhibitory activity that the mouthwashes have per se;
furthermore, it determines the relative efficacy of the different formulations being
considered as predictable of the antiplaque effect of an antiseptic.
In addition, another important factor in the study in vivo of an oral antiseptic is the
necessity to conserve intact the oral biofilm at all stages: formation, recollection and
analysis of the oral samples. This is in order not to interfere the delicate three
dimensional structure of the oral biofilm which has been proven to be essential in the
resistance to the effects of an external antiseptic agent. For these reasons, the study of
the oral biofilm with the help of intraoral disks hold in specially designed apparatus
combined with the application of the Confocal Laser Scanning Microscopy have proved to be
very valuable at the study of the oral biofilm in its intact hydrated natural state.
Since an alcohol free formulation of the EO have come up to the market, it seems convenient
to compare its effects to the traditional one. Although some studies comparing the effects
of T-EO and Af-EO have been found, none of them assessed and compared their substantivity
and antiplaque effect in an in vivo model of structured oral biofilm. For this reason, the
aim of the present study was to compare the in vivo antibacterial effect (immediate effect,
substantivity and antiplaque effect) of the EO with and without alcohol in structured oral
biofilm.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04712630 -
Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft
|
N/A | |
Completed |
NCT06127069 -
Treatment of Residual Pockets in Periodontal Patients Using an Oscillating Chitosan Device
|
N/A | |
Completed |
NCT04964167 -
Indocyanine-green Mediated Photosensitizer VS Aloe Vera Gel: Adjunct Therapy to Scaling and Root Planing in Patients With Chronic Periodontitis
|
Phase 4 | |
Completed |
NCT05906797 -
Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.
|
N/A | |
Recruiting |
NCT03997552 -
NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration
|
N/A | |
Completed |
NCT05530252 -
Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis
|
Phase 4 | |
Completed |
NCT04881357 -
Antiplaque/Antigingivitis Effect of Lacer Oros Integral
|
N/A | |
Recruiting |
NCT03790605 -
A Clinical Trial to Study the Effect of a Drug, Curcumin in Patients With Periodontitis
|
Phase 3 | |
Enrolling by invitation |
NCT04971174 -
Outcomes of Periodontal Regenerative Treatment
|
||
Not yet recruiting |
NCT05568290 -
Interleukin-38 Levels in Individuals With Periodontitis
|
||
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Recruiting |
NCT03997578 -
Non-incised Papillae Surgical Approach (NIPSA) and Connective Tissue Graft Plus Emdogain for Periodontal Defects
|
N/A | |
Completed |
NCT03901066 -
Smoking Dependence and Periodontitis
|
||
Enrolling by invitation |
NCT04956211 -
Periodontal Treatment and Ischemic Stroke
|
N/A | |
Recruiting |
NCT05971706 -
Ozone Application in Periodontal Treatment
|
N/A | |
Recruiting |
NCT06099574 -
A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
|
||
Completed |
NCT04402996 -
Meteorin-like Levels in Individuals With Periodontitis
|
||
Active, not recruiting |
NCT05311657 -
Oral Health and Severe COPD
|
||
Not yet recruiting |
NCT06453278 -
(DDS) in India: a Screening Tool to Identify Prediabetes and Undiagnosed Type 2 Diabetes in Dental Settings
|
||
Not yet recruiting |
NCT05643287 -
The Effect of Time on the Outcome of Periodontal Treatment.
|
N/A |